Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the sciatic nerve block with EXPAREL for bunionectomy has completed and results were posted. The study was sponsored by Pacira Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Bunionectomy, Hallux Valgus | Phase 3 | Status: COMPLETED | Results posted: 2025-06-26